Spinal Restoration (Austin, TX), a clinical stage biotechnology company focused on the treatment of discogenic chronic low back pain, closed a $5M Series C financing. Participants include Austin Ventures, Santé Ventures, MB Venture Partners and Comerica Bank.

___________

Collective IP the Most Comprehensive and Accurate View of Global Innovation and Organization of the International Technology Transfer Office Ecosystem